Redefining Therapeutic Outcomes of Depression Treatment
- PMID: 33569141
- PMCID: PMC7842646
- DOI: 10.17505/jpor.2019.10
Redefining Therapeutic Outcomes of Depression Treatment
Abstract
Responses to evidence-based interventions for depression are divergent: Some patients benefit more than others during treatment and some do not benefit at all or even deteriorate. Tailoring interventions to the individual may improve outcomes. However, such personalization of evidence-based treatment in depression requires investigation of individual outcomes and the individual trajectories towards these outcomes. This theoretical paper provides a critical reflection on individual outcomes of depression treatment. First, it is argued that outcomes should be broadened, from a focus on mainly depressive symptomatology to recovery in different domains. It is acknowledged that recovery from depression reflects a personal journey that differs from person to person. Second, outcome measures should be lengthened beyond the acute treatment phase, taking a lifetime perspective on depression. The challenge then is to discover which trajectories of what measures during what interventions result in personalized sustainable recovery and for whom. Routine outcome monitoring systems may be used to inform this quest towards assessment of personalized sustainable therapeutic outcomes. Adaptations to broaden and lengthen measurements in routine outcome monitoring systems are proposed to identify predictors of personalized sustainable recovery. Routine outcome monitoring systems may eventually be used to implement personalized treatments for depression that result in personalized sustainable recovery.
Keywords: Depression; Personalized sustainable recovery; Personalized treatment; Routine Outcome Monitoring; Therapeutic outcomes.
© Person-Oriented Research.
Conflict of interest statement
The authors declare that there is no conflict of interest.
References
-
- Bakker J. M., Lieverse R., Geschwind N., Peeters F., Myin-Germeys I., & Wichers M. (2016). The two-sided face of antidepressants: The impact of their use on real-life affective change during mindfulness-based cognitive therapy. Psychotherapy and Psychosomatics , 85(3), 180-182. 10.1159/000443333 - DOI - PubMed
-
- Bastiaansen J. A., Meurs M., Stelwagen R., Wunderink L., Schoevers R. A., Wichers M., & Oldehinkel A. J. (2018). Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: A protocol of a pragmatic randomized controlled trial (ZELF-i). BMC Psychiatry , 18(1), 276 10.1186/s12888-018-1847-z - DOI - PMC - PubMed
-
- Cipriani A., Furukawa T. A., Salanti G., Chaimani A., Atkinson L. Z., Ogawa Y., . . . Geddes J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357-1366. 10.1016/S0140-6736(17)32802-7 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources